Jaana Hagström - UTU Research Portal

Jaana Hagström

Institute of Dentistry (Faculty of Medicine)

jaana.hagstrom@utu.fi

+358 50 427 1914

13 of 27

The prognostic role of tissue TLR2 and TLR4 in colorectal cancer (2020)
- Virchows Archiv
Ines Beilmann-Lehtonen, Camilla Böckelman, Harri Mustonen, Selja Koskensalo, Jaana Hagström, Caj Haglund
Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer (2020)
- Oncology
Ahopelto K, Laitinen A, Hagström J, Böckelman C, Haglund C
B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets (2019)
- Scientific Reports
Edin S, Kaprio T, Hagström J, Larsson P, Mustonen H, Böckelman C, Strigård K, Gunnarsson U, Haglund C, Palmqvist R
Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome (2019)
- Scientific Reports
Kasurinen A, Hagström J, Laitinen A, Kokkola A, Böckelman C, Haglund C
High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer (2019)
- Cancer Immunology, Immunotherapy
Carpén T, Sorsa T, Jouhi L, Tervahartiala T, Haglund C, Syrjänen S, Tarkkanen J, Mohamed H, Mäkitie A, Hagström J, Mattila PS
High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1. (2019)
- Cancer Medicine
Kasurinen A, Gramolelli S, Hagström J, Laitinen A, Kokkola A, Miki Y, Lehti K, Yashiro M, Ojala PM, Böckelman C, Haglund C
Human β-Defensin 2 Expression in Oral Epithelium: Potential Therapeutic Targets in Oral Lichen Planus (2019)
- International Journal of Molecular Sciences
Salem A, Almahmoudi R, Hagström J, Stark H, Nordström D, Salo T, Eklund KK
In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer (2019)
- Human Pathology
Randén-Brady R, Carpén T, Jouhi L, Syrjänen S, Haglund C, Tarkkanen J, Remes S, Mäkitie A, Mattila PS, Silén S, Hagström J
Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer (2019)
- PLoS ONE
Kaprio T, Rasila T, Hagström J, Mustonen H, Lankila P, Haglund C, Andersson LC
Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer (2019)
- Head and Neck
Pakkanen PP, Aaltonen LM, Sorsa TA, Tervahartiala TI, Hagström JK, Ilmarinen TT